Using cannabis can lead to more emergency room visits and higher pain for people with multiple sclerosis.
The study looked at how cannabis use affects different neurological conditions, including multiple sclerosis (MS). They found that people with MS who used cannabis went to the emergency room more often for help with pain compared to those who didn’t use it. For example, 25.8% of MS patients using cannabis needed emergency care, while only 19.3% of non-users did. This means that using cannabis might make pain worse for people with MS. Although there were hints that cannabis users might also face higher risks of serious issues like stroke, the differences weren’t strong enough to be certain.
This information is important for MS patients and caregivers because it shows that cannabis might not help with pain and could lead to more trips to the hospital. Just like taking a wrong turn can lead you to a dead end, using cannabis may not lead to the relief you hope for. Caregivers should be aware of this so they can help manage pain in other ways. Healthcare providers can use this knowledge to guide their patients in making safer choices about cannabis use. Overall, understanding these risks can help improve daily life and treatment plans for people living with MS.
The study had some limitations, such as not being able to follow all patients for the same amount of time. This means that some of the findings may not apply to everyone with MS or other neurological conditions. It’s essential for patients and caregivers to discuss these findings with their healthcare team to understand how they might specifically relate to their situation.
12/1/2025
Learn how anti-NMDAR encephalitis overlaps with MS and what it means for treatment and symptom manag
Read More12/1/2025
Learn how the PHH-1V booster shot could provide better COVID protection for MS patients and their ca
Read More12/1/2025
Discover how dignity affects family caregivers of MS patients and why their feelings matter for bett
Read More12/1/2025
Learn how studying certain viral genes in our DNA may lead to better MS treatments and improve sympt
Read More12/1/2025
Discover how gut bacteria may boost cognitive function in MS patients and why gut health matters for
Read More12/1/2025
Discover how targeting Piezo1 in immune cells could change MS management and improve symptoms for pa
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of the neurological sciences often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.